Market capitalization | DKK35.58b |
Enterprise Value | DKK35.55b |
P/E (TTM) P/E ratio | 109.12 |
EV/FCF (TTM) EV/FCF | 52.59 |
EV/Sales (TTM) EV/Sales | 6.30 |
P/S ratio (TTM) P/S ratio | 6.30 |
P/B ratio (TTM) P/B ratio | 6.14 |
Dividend yield | 0.28% |
Last dividend (FY24) | DKK0.38 |
As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.
11 Analysts have issued a Ambu forecast:
11 Analysts have issued a Ambu forecast:
Dec '24 |
+/-
%
|
||
Revenue | 5,647 5,647 |
15%
15%
|
|
Gross Profit | 3,337 3,337 |
22%
22%
|
|
EBITDA | 1,125 1,125 |
69%
69%
|
EBIT (Operating Income) EBIT | 428 428 |
19%
19%
|
Net Profit | 326 326 |
37%
37%
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Head office | Denmark |
CEO | Britt Jensen |
Employees | 5,196 |
Founded | 1937 |
Website | www.ambu.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.